Identifying Prognostic Gene Signatures for Breast Cancer
Author Information
Author(s): Kim Seon-Young, Kim Yong Sung
Primary Institution: Human Genomics Laboratory, Functional Genomics Research Center, KRIBB, Daejeon, Korea
Hypothesis
Can a gene sets approach improve the identification of prognostic gene signatures for breast cancer outcomes?
Conclusion
The gene sets approach is effective for developing prognostic gene sets that can predict patient outcomes in breast cancer.
Supporting Evidence
- The gene sets approach identified many prognostic gene sets related to biological processes like cell cycle and proliferation.
- External validation showed that the best gene set had a prediction accuracy of 67.55%.
- Many gene sets were found to have additional prognostic value over conventional clinical parameters.
Takeaway
Researchers looked at many gene sets to find which ones can help predict how breast cancer patients will do. They found some that work really well!
Methodology
The study analyzed 12 independent breast cancer gene expression datasets using a gene sets approach to identify prognostic gene sets.
Potential Biases
Potential biases may arise from the selection of datasets and gene sets used in the analysis.
Limitations
The study may have limitations related to the generalizability of the identified gene sets across different populations and datasets.
Participant Demographics
The study included diverse breast cancer patients with varying clinical characteristics.
Statistical Information
P-Value
0.0256
Confidence Interval
(1.23–32.2)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website